Industry Payments to Cardiologists Are Associated With Higher Medicare Spending

Read full text Summarise with VIRAT
Authors: Michael I. Ellenbogen, Joseph Edward Marine, Yubin Park, Brady Post
Cited by: 0
References: 48

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

OBJECTIVE: To determine whether industry payments to cardiologists are associated with Medicare beneficiary spending, as financial incentives may influence clinical decision-making. STUDY DESIGN: Cross-sectional analysis comparing 2022 Open Payments data with cardiologists' attributed traditional Medicare spending. METHODS: We used publicly available data on industry payments to providers (Open Payments) and professional fees per provider for traditional Medicare beneficiaries for 2022. We estimated a multivariable linear regression with cardiologist-attributed spending per traditional Medicare beneficiary as the outcome and nonresearch industry payments as the predictor of interest. For the main analysis, we adjusted for cardiologist characteristics and patient characteristics and included a fixed effect for state of practice. RESULTS: Our sample included 26,805 cardiologists, and of these, 82.3% received at least 1 payment. The mean (SD) industry payment to cardiologists was $3958 ($17,471). In the main model, a $10,000 increase in industry payments was associated with greater mean spending per Medicare beneficiary by $14.1 (95% CI, $11.9-$16.3). CONCLUSIONS: Industry payments were positively correlated with spending per traditional Medicare beneficiary attributed to a given cardiologist. Although our analysis does not establish causation, the relationship between industry payments and attributed spending is potentially significant, even if industry payments directly influence only a fraction of the overall expenditure. Future studies should better characterize the relationship between payments from device and pharmaceutical companies and spending for those specific devices and drugs and use causal methods to measure the extent to which these payments may influence health care utilization.

Fields of Study & Subjects

Pharmaceutical industry and healthcare Healthcare Policy and Management Political Influence and Corporate Strategies

Publication details

Journal / source
The American Journal of Managed Care
Volume
32
Issue
3
Pages
166–166
Publication date
1 March 2026
Language
EN